Recent population-based studies of measles incidence and deaths in Sudan are not available. To determine the epidemiology and case-fatality rate (CFR) of measles, we conducted a retrospective outbreak investigation in two states in northern Sudan. Of 1144 case-patients identified, 92% were <15 years; 48.6% were vaccinated; and 62% received vitamin A before illness. Ten measles-associated deaths were identified (CFR 0.9%; 95% confidence interval 0.16-1.91). CFR determined by this investigation is lower than expected for the region but remains 10 times higher than that in developed countries. Measles control should be strengthened by improving vaccine coverage, measles surveillance and case-management.
Sudan is one of five countries in the World Health Organization's Eastern Mediterranean Region in the mortality-reduction phase of measles control [1] , which emphasizes improving routine vaccination coverage and improving measles surveillance, conducting measles supplementary immunization activities, and ensuring appropriate case management for measles case-patients. Population-based studies conducted before the introduction of measles vaccine in Sudan in 1985 describe measles as the highest cause of mortality caused by a vaccine-preventable disease among children aged 5 years (unpublished data, Sudan Ministry of Health [MOH] ). However, more recent population-based studies of measles incidence and deaths have not been conducted.
Measles vaccination coverage in Sudan was estimated to be 70% in 2003 (unpublished data, Sudan MOH). However, a joint 2003 WHO and UNICEF population survey demonstrated an overall measles vaccination coverage of 57% and wide geographic variation (from <1% in Southern Sudan to 100% in Eastern Sudan). In October 2003, a large outbreak of >3000 measles cases was reported. Khartoum and White Nile states, accounted for approximately 54% of reported cases during October 2003-April 2004. We conducted a community-based retrospective investigation of the measles outbreak in Khartoum and White Nile states to understand the epidemiology of measles in Sudan and estimate CFR.
Methods
Two states were selected for a retrospective community-based investigation based on high incidence of laboratory-confirmed measles cases, accessibility to villages, and rural/urban diversity. White Nile, a rural state with a population of approximately 1 600 000 and an estimated measles vaccination coverage of 83% in 2003 (unpublished data, Sudan MoH); and Khartoum, a state with a population of approximately 5 800 000 and including both urban and peri-urban areas and an estimated measles vaccination coverage of 67% in 2003 (unpublished data, Sudan MoH).
Within each state, the locality and, within the locality, the administrative unit with the largest number of reported measles cases was selected. This led to the selection of the administrative units of Jenub Rabak in White Nile state (population 91 000) and Kharary Reef in Khartoum state (population 75 000). Within these administrative units, 10 villages were randomly selected for investigation. Laboratory confirmation of measles transmission was available for each administrative unit selected. Rubella testing, however, was not available.
A measles case-patient was defined as a person with fever, generalized maculo-papular rash and at least one of the following: cough, coryza, or conjunctivitis. A measles death was defined as a death of a measles case-patient within 30 days of rash onset, unless another clearly stated non-related cause existed (e.g., trauma, homicide, etc) [2] . All measles case-patients with rash onset during October 1, 2003 to April 30, 2004, defined as the recall period, and known disease outcome (i.e., dead or alive) for a period of 30 days after rash onset were included in the investigation; measles case-patients with rash onset within 30 days of the survey date were excluded because their outcome at 30 days after rash onset could not be determined.
To determine CFR, a minimum sample size of 376 case-patients was calculated to be required in each location, assuming a true CFR of 2%, a precision of AE2%, an alpha of 5%, and a design effect of 2.
Within all selected villages, a comprehensive house-to-house search was conducted for measles case-patients. Following consent, the respondent was interviewed using a data collection tool that collected information on demographics, details of the illness and patient outcome. The respondent was usually the mother of the case-patient, but if the mother was unavailable, another adult family member was interviewed. Information collected was based on respondent recall. Vaccination cards were not available in the majority of cases, but when available, they were used to confirm vaccination status.
The protocol for this investigation was approved by the WHO's Secretariat Committee on Research Involving Human Subjects and the Sudan Federal Ministry of Health Ethical Review Committee. Analyses were performed by using SAS [3] software and CSAMPLE contained in Epi-Info [4] software.
Results
We identified 1144 measles case-patients in the two areas investigated: 621 in White Nile state, and 523 in Khartoum state. The epidemic curves from both areas indicate that in White Nile state, the outbreak had two major peaks during February and April 2004 ( Figure 1) ; in Khartoum state, the outbreak peaked during February 2004 ( Figure 2 ). Casepatients were evenly distributed by sex (50.1% male) (Table 1) , and ages ranged from 5 months to 39 years (mean: 7.0 years; median: 6.0 years). Overall, 448 (39%) case-patients were aged <5 years; 843 (74%) were <10 years, and 1053 (92 %) were <15 years. Thirty-six (3.1%) case-patients were aged <1 year.
Prior measles vaccination was reported for 556 (49.6%) case-patients. Among children aged 1-5 years, approximately 42% of case-patients in White Nile, and 64% of case-patients in Khartoum reported receiving measles vaccinations. Reported measles vaccination was positively associated with proximity to a health-care facility, with 450 (81%) of the case-patients living within 30 min by foot from a health-care facility having been vaccinated against measles in comparison with only 106 (19%) among those living >30 min away ( p < 0.001). Of 448 casepatients aged <5 years, 276 (62%) reported receiving routine vitamin A supplementation before onset of measles.
A total of 632 (55%) case-patients sought treatment at a health-care facility. Of these, only 148 (23%) reported receiving vitamin A as part of treatment. Of the 1144 case-patients investigated, 66 (6%) reported being hospitalized; duration of admission ranged from 1-15 days (mean: 3.7 days; median: 3 days). In White Nile state, 257/621 (41%) case-patients sought treatment at a health-care facility. Case-patients who sought treatment were 1.4 times more likely to live within a 10-minute walk of the health-care facility than case-patients who had not sought treatment (p ¼ 0.001). In Khartoum state, 375/523 case-patients (72%) sought treatment and those who sought treatment were 1.2 times more likely to live within a 10-minute walk from the health-care facility than case-patients who had not sought treatment (p ¼ 0.004).
Our survey identified 621 cases in Jenub Rabak administrative unit in White Nile state, and 521 cases in Kharary Reef administrative unit in Khartoum state. During the same recall period, existing surveillance systems reported 133 and 465 cases throughout Jenub Rabak and Kharary Reef, respectively. Because 512 (45%) case-patients did not visit a health-care facility, these case-patients might not have been reported by existing surveillance systems.
Among the 1144 case-patients investigated, 10 died within 30 days of rash onset, thus meeting the definition of a measles-associated death. This corresponds to a CFR of 0.9% (95% CI 0.16-1.91). Eight of these deaths occurred in White Nile state, for a state-specific CFR of 1.3% (95% CI 0.5-3.1). In contrast, only two deaths occurred in Khartoum state, for a CFR of 0.4% (95% CI 0.2-1.0).
Of these deaths, 60% occurred in the first 3 weeks after rash onset. Seven of 10 deaths occurred among children aged 1-5 years. Of the 10 case-patients who died, seven had no history of measles vaccination; two were reported to have received measles vaccination, and for one case, the vaccination status was unknown.
Discussion WHO estimates indicate that >595 000 cases of measles and 17 000 measles-associated deaths occur in Sudan annually (WHO unpublished data). Although the CFR determined during this investigation is low relative to that estimated by WHO in most low-income countries, it is still approximately tenfold higher than that observed in developed countries [5, 6] . Furthermore, the availability of an efficacious and relatively inexpensive vaccine makes even this low figure unacceptable [7] . The relatively low CFR compared with that reported historically in Sudan [8] [9] and other African countries [10] might be the result of better access to health care and higher vaccination coverage in the areas investigated.
Seventy-four percent of case-patients were aged <10 years, with 3.2% aged 1 year. This is consistent with areas of ongoing transmission and low vaccine coverage, where a majority of the population is exposed to measles virus at an early age. Assuming that the age distribution of cases in the community is similar to that observed in this investigation, these results might be useful in defining the age range of future measles vaccination campaigns.
Approximately half the case-patients reported having been vaccinated for measles. Among children aged 1-5 years, approximately 42% of case-patients in White Nile state and 64% of case-patients in Khartoum state reported having previous measles vaccination. This is contrary to what is expected with the area with lower coverage (Khartoum) reporting more vaccinated cases, while the area with the relatively higher coverage (White Nile) reporting a relatively lower number of vaccinated cases. These discrepancies might be the result of errors in recording vaccination history, inaccurate vaccination coverage figures, or a combination of the two. In addition, the vaccination coverage in the specific areas investigated might be substantially different from the overall coverage figures for the two respective states. Our investigation identified a difference between the CFRs in the two states, being lower in Khartoum (CFR 1%). There are several possible explanations for this difference. First, as discussed previously, although the overall reported vaccination coverage in White Nile state is higher than in Khartoum state, the area investigated in Khartoum state might have higher vaccination coverage than the area investigated in White Nile state. Second, access to health-care facilities and case management may be better in Khartoum state. Among case-patients investigated in Khartoum, 72% sought treatment at a health-care facility, and 30% received treatment with vitamin A while in White Nile state, 41% sought treatment and only 14% received vitamin A.
Although measles case management at health-care facilities was not assessed, the finding that only a limited proportion of case-patients who sought treatment received vitamin A indicates suboptimal case management at health-care facilities. Third, the nutritional status of the population in Khartoum state might be better that in White Nile state. Our investigation did not collect information on nutritional status; however, according to data from Multi Indicator Cluster Surveys conducted in 2000 moderate malnutrition among children aged <5 years was 21.8% and 13.9% in White Nile and Khartoum states, respectively.
This investigation also indicates that measles cases continue to be underreported by existing surveillance systems in Sudan. Our data demonstrate that underreporting occurred more in White Nile state and may be a result of poor access to health-care facilities. However, we were unable to link case-patients identified during our investigation with those reported by the surveillance system and could not quantify the extent of underreporting. The investigation had the following limitations. First, the low number of measles-associated deaths did not permit the analysis of the relative contributions of the known risk factors for measles mortality. Second, information on onset of illness, death and vaccination status of measles case-patients were based on respondent recall and might have resulted in recall errors. However, the recall period for this investigation was relatively short and it is unlikely that such errors occurred often enough to substantially affect the overall results. Furthermore, households reporting these deaths were revisited during the investigation to ensure that case-patients met the clinical case definition and confirm dates of death. Third, although we attempted a comprehensive search for measles cases and deaths in the selected areas, some measles cases or deaths may have been missed or intentionally not reported. In particular, case-patients who died following measles might have been underreported by respondents because of reluctance to talk about a sad event. Finally, laboratory confirmation of measles transmission was not available from all villages investigated. However, laboratory confirmation of measles transmission was available from all administrative units selected. All villages in which laboratory confirmation was not possible were proximal to villages with laboratory-confirmed measles transmission and therefore likely to be a part of the same outbreak.
Almost all deaths identified in this investigation were preventable through vaccination; continued efforts to raise measles vaccine coverage in Sudan are required to prevent measles outbreaks and related deaths. Vaccination coverage should be raised through strengthening routine immunization, conducting wide age-range measles vaccination campaigns, improving measles surveillance and ensuring appropriate case management. 
